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S U M M A R Y
Objectives: Clinical diphtheria is on the increase worldwide, mainly affecting developing countries. We
sought to understand its presentation among patients at Sir Ronald Ross Institute of Tropical and
Communicable Diseases in Hyderabad, Andhra Pradesh, India.
Methods: Diphtheria patients presented with fever, pharyngitis, and a patch in the throat. Data collected
for each patient included age, clinical presentation, morbidity, mortality, bacteria isolated from culture,
and immunization status.
Results: Of 61 950 admissions from January 2008 to December 2012, 2925 (4.7%) had clinical diphtheria;
1194 had been immunized and 1731 were non-immunized. Immunized patients had a milder disease.
Culture-positive immunized patients were positive for Corynebacterium other than diphtheriae (COD;
n = 104) or Corynebacterium diphtheriae (CD; n = 23); these patients suffered mild disease and recovered
completely. In contrast, culture-positive non-immunized patients were positive for COD (n = 11) or CD
(n = 412). Eighty-one patients (3%) died, 77 of whom were non-immunized; death was usually as a result
of myocarditis. Seventy-three percent of deaths were in patients aged <5 years.
Conclusions: The clinical presentation of diphtheria and its severity and morbidity differ considerably in
immunized and non-immunized patients. Disease caused by CD can be deadly, while disease due to COD
is mild and responds to treatment.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Diphtheria is an acute infectious disease of the upper
respiratory system caused by toxigenic strains of Corynebacterium
diphtheriae/Corynebacterium other than diphtheriae. The organisms
are locally invasive and secrete soluble exotoxins, which can lead
to serious consequences mainly involving the heart muscle and
nervous system. Death can occur due to circulatory failure within
the ﬁrst 10 days of infection.1 If diagnosed early, the infection
responds to appropriate antibiotics and prompt antitoxin therapy.
The incidence of diphtheria is high in India, especially in the
state of Andhra Pradesh. Factors contributing to morbidity and
mortality include patient’s immunization status, age at infection,
time of infection, clinical type, and time of intervention. Clinical
correlation with laboratory ﬁndings (microscopy and culture)
helps in the conﬁrmation of the diagnosis, and onward transmis-
sion of data helps the health authorities to spread awareness, boost       
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http://dx.doi.org/10.1016/j.ijid.2013.10.017immunization programs, and prevent community spread. Early
diagnosis and timely intervention help to reduce the incidence,
containing the infection in the community and decreasing
morbidity and mortality in the affected individuals.2,3
The aim of this study was to assess the incidence of clinical
diphtheria and its mode of presentation, trends of the disease, such
as the frequency in children and adults, seasonal variation, gender
predisposition, relationship between clinical disease and immuni-
zation status, the role and limitations of laboratory investigations,
and most importantly, the variation in clinical presentation of
disease due to Corynebacterium diphtheriae (CD) and Corynebacte-
rium other than diphtheriae (COD).
2. Materials and methods
This study was done at Sir Ronald Ross Institute of Tropical and
Communicable Diseases (SRRITCD), Hyderabad, India from January
2008 to December 2012. A total 61 950 patients were admitted
during this period. Of these, 2925 cases of clinical diphtheria were
admitted to the isolation ward of the hospital.
Study inclusion criteria were those of US Centers for Disease
Control and Prevention;4,5 patients of all ages presenting with
fever and a sore throat with a grayish white membrane were
included. The following patients were excluded: those who diedciety for Infectious Diseases. Open access under CC BY-NC-ND license.
Table 1
Characteristics of the two diseases: Corynebacterium diphtheriae (CD) and
Corynebacterium other than diphtheriae (COD)a
Clinical features CD
(n = 435)
COD
(n = 115)
Immunized
(n = 1194)
Non-immunized
(n = 1731)
Fever 435 115 1194 1731
Throat pain/dysphagia 435 115 1194 1731
Membrane 435 115 1194 1731
Rhinorrhea 184 41 603 1240
Vomiting and
abdominal pain
45 14 417 431
Laryngitis 435 46 960 1028
Lymphadenitis/neck
edema
187 93 424 553
Stridor 91 - - 270
Evidence of myocarditis 83 - - 540
Soft tissue swelling 187 - 91 553
Pneumonitis 47 - 40 101
% Immunized 5 95 - -
No. of deaths - - 4 77
Raised ESR 435 115 601 1231
Albuminuria 435 74 507 1047
KLB 92 - - -
ESR, erythrocyte sedimentation rate; KLB, Klebs–Lo¨fﬂer bacillus.
a Interpretation: (1) There was a signiﬁcant occurrence of lymphadenitis, stridor,
myocarditis, soft tissue swelling, and pneumonitis in CD positive and non-
immunized patients compared to COD positive and immunized patients; (2) 95% of
immunized patients were COD positive compared to 5% CD; (3) the number of
deaths was signiﬁcantly greater in the non-immunized (n = 77) than in the
immunized.
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left the hospital against medical advice.
The immunization status was documented as per the informa-
tion given by the parents those attending with the patient/
individuals. Those who had received three primary doses at 4–6-
week intervals starting at 1 month of age, followed by booster
doses at 18 months and 5 years were recorded as immunized.
Those who had not received any dose were considered unimmu-
nized. Patients who did not receive all three primary doses or
booster doses were included as partially immunized. For statistical
purposes unimmunized and partially immunized patients were
considered together as non-immunized.
The following data were recorded: age, sex, clinical symptoms
and signs, laboratory ﬁndings including smear for Klebs–Lo¨fﬂer
bacillus (KLB) and culture, complete blood picture (CBP), erythro-
cyte sedimentation rate (ESR), and albuminuria, and the outcome.
Patients were categorized into ﬁve age groups: <5, 5–20, 20–30,
30–40, and >40 years. Clinical features other than those of the
inclusion criteria were noted for each patient.
Throat swabs for direct microscopy for KLB and culture for
corynebacteria were collected soon after admission and repeated
on day 5 for each patient. Staining of the smears was done by
Albert–Laybourn method and culture on Lo¨fﬂer’s serum (early
growth, 4–6 h), blood agar (enriched medium), potassium tellurite
medium (selective for corynebacteria), and Tinsdale/diphtheria
virulence agar (supports the growth of toxigenic strains). Growth
after 24–72 h incubation was processed biochemically (glucose,
maltose, sucrose, trehalose, starch, glycogen, urease, cysteinase,
and gelatin liquefaction). Practically, growth on Tinsdale/diphthe-
ria virulence agar was taken as evidence of toxigenicity of the
strain. CD and COD (Corynebacterium ulcerans, Corynebacterium
jeikeium, and Corynebacterium arcanobacterium) were identiﬁed
based on differences in biochemical reactions, as per standard
methods.6 Other investigations included CBP, ESR, and examina-
tion of urine for albumin. An electrocardiogram (ECG) was taken
for each patient soon after admission, on every alternate day
during the inpatient stay, and at the time of discharge.
The statistical analysis was done using SPSS software v. 17.0
(SPSS Inc., Chicago, IL, USA).
3. Results
All patients (N = 2925) presented with fever, sore throat, and a
pseudomembrane. Mild to moderate laryngitis was observed in
67%, rhinorrhea in 63%, and lymphadenopathy and edema in the
neck region were seen in 33% of cases. Features of acute respiratory
obstruction in the form of stridor were seen in 9% of cases at the
time of admission. Vomiting and abdominal pain were seen in 29%
of patients. Signs and symptoms suggestive of myocarditis
developed in 16% of cases (vomiting and abdominal pain along
with low blood pressure and tachycardia) 1–2 days after admission
(Table 1).
One thousand one hundred and ninety-four (41%) patients gave
a history of complete immunization (Table 1), 236 (8%) cases were
partially immunized, and 1257 (43%) were unimmunized; the
immunization status was not known for 238 cases (8%). For
statistical analysis, the partially immunized, unimmunized, and
those with an unknown immunization status were considered as
non-immunized individuals – 1731 cases (59%) (Table 1).
Females were found to be more affected (60%) in comparison to
males (40%) (Figure 1). A binomial test was done to show the
statistical signiﬁcance of gender susceptibility (p > 0.05).
The distribution of cases by age showed 1540 out of 2925 cases
(52.6%) were adults (20 years), while 1385 (47.3%) were children
and adolescents. The disease occurred at an earlier age in the
immunized, peaking between 5 and 20 years of age, while in thenon-immunized the disease peaked in those aged 20–30 years
(Table 2).
The disease showed seasonal variation (Figure 2), with a peak
incidence in the month of September (71 cases on average). The
peak of disease among the vaccinated cases occurred in the month
of October (33 cases on average) and the peak among the
unvaccinated occurred in September (45 cases on average).
Culture was done for 2905 patients. CD/COD were isolated from
throat swab cultures of 550 (18.8%) patients. Among the
immunized patients, CD was isolated from 23 (5%) and COD from
104 (95%), while among non-immunized patients, CD was isolated
from 412 and COD from 11 (p < 0.0001), as shown in Table 3.
The clinical illness was found to be milder in COD-positive cases
(n = 115) when compared to CD-positive cases (n = 435). All
features of complicated diphtheria were seen in CD-positive and
non-immunized cases (Table 1). Apart from the inclusion criteria,
laryngitis was seen among COD-positive cases, while laryngitis,
lymphadenitis, stridor, myocarditis, soft tissue swelling, and
pneumonitis were seen among CD-positive cases (Table 1).
Ninety-ﬁve percent of COD-positive cases were immunized,
while the rate of immunization was 5% among CD-positive cases
(Table 1).
KLB were seen in smears of 92 CD-positive cases. A raised ESR
and abnormal CBP showing leukocytosis with relative neutrophilia
were reported in all CD- and COD-positive (100%) cases. Severe
albuminuria was observed in all CD-positive (100%) and 74 COD-
positive cases. While KLB detected 21% of CD-positive cases, ESR,
CBP, and albuminuria did not distinguish between CD- and COD-
positive cases.
Two thousand three hundred and four (81%) cases were
completely cured and discharged. The average duration of
inpatient stay was 7–10 days.
Five hundred and forty patients (16%) who had mild
myocarditis were followed up until complete recovery. Of these,
13% suffered from dyspnea and 3% complained of chest pain, while
80% showed ECG abnormalities in the form of conduction blocks
and arrhythmias.
Figure 1. Cases of diphtheria by year, gender, and immunization status.
Table 2
Immunization status in relation to age groupa
Status Age group, years
<5 5–20 20–30 30–40 40–50 50–60 >60 Total
Immunized 154 508 312 154 60 2 4 1194
Non-immunizedb 323 400 815 146 25 18 4 1731
Total 477 908 1127 300 85 20 8 2925
a Among the immunized, the age group most commonly affected was 5–20 years, while among the non-immunized it was 20–30 years.
b Non-immunized include unimmunized and partially immunized.
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unimmunized and four (<2 years) were immunized. Fifty-nine
were in the age group 5–20 years, 18 were 10–20 years, and four
were 20–40 years, while no deaths occurred in those >40 years of
age (Table 4). All of them presented with additional clinicalFigure 2. Immunization patterns by month and gender. The numbers from 0 to features suggestive of complicated diphtheria, apart from the
inclusion criteria, at the time of admission. The average time to
death was 1–5 days.
The death rate was found to be almost equal in males and
females (p > 0.05). All deaths were due to myocarditis, except one45 indicate the average number of cases in each month from 2008 to 2012.
Table 4
Deaths in relation to age and gendera
Age group, years Deaths Male Female
<5 59 26 33
5–20 18 7 11
20–30 3 2 1
30–40 1 1 0
>40 Nil - -
a Chi-square = 2.08; p-value = 0.556; total number of deaths = 81; maximum
number of deaths below 10 years = 59; no deaths above 40 years. There was no
signiﬁcant difference in the number of deaths between males and females across
the various age groups.
Table 3
Results of throat swab culture: immunized and non-immunized individualsa
Immunization status CD COD CD/COD not isolated
Immunized 23 104 1067
Non-immunized 412 11 1288
Total 435 115 2355
CD, Corynebacterium diphtheriae; COD, Corynebacterium other than diphtheriae.
a Chi-square = 364.03; p-value = 0.0001; total number of patients = 2925. Culture
was done for 2905 cases. No laboratory tests were done for 20 cases.
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done for 61 cases showed increased ESR, KLB positivity in 41
patients, and CD isolated from 32 patients. No laboratory tests
could be done for the 20 patients who died soon after admission.
4. Discussion
Diphtheria, if not detected early and treated, can lead to
signiﬁcant mortality and morbidity because of critical complica-
tions such as myocarditis, obstructive airway disease, polyneuritis,
cranial nerve palsies, disseminated intravascular coagulation, and
secondary pneumonia. All 2925 cases of clinical diphtheria
admitted to SRRITCD from January 2008 to December 2012 were
of the nasopharyngeal type (100%) and presented with mild to
moderate fever, sore throat, and a pseudomembrane on examina-
tion (100%). Additional presenting features included malaise,
throat pain, cough, rhinitis, vomiting, abdominal pain, chest pain,
palpitations, dyspnea, orthopnea, dysphagia, and perspiration. On
examination, tachycardia, tachypnea out of proportion to fever,
cervical lymphadenitis, bilateral crepitations, and wheeze in the
lungs were found. The age at infection, course of the clinical illness,
results of throat swab culture, morbidity and mortality varied
signiﬁcantly between those who were not immunized and those
who were immunized.7 It was clearly observed in the present
study that clinical diphtheria in non-immunized CD-positive
patients presented differently from that in immunized COD-
positive patients. Among non-immunized patients, features such
as lymphadenitis, stridor, myocarditis, soft tissue swelling, and
pneumonitis were either present at the time of admission or
developed within 1–2 days of the hospital stay. CD was isolated
predominantly from these patients.
Since toxin-mediated inhibition of protein synthesis is known
to be the essential mechanism of all complications of diphtheria,
especially myocarditis, as the exotoxin is directly cardiotoxic and
can cause DNA fragmentation and cytolysis by inhibiting elonga-
tion factor-2 activity in protein synthesis8,9 leading to tissue
damage, non-immunized and CD-positive patients developed
complications associated with diphtheria (Table 1).
The clinical illness and outcome varied in different age groups.
Among the immunized, the most common age group affected was
5–20 years, while among the non-immunized, it was 20–30
years.10 Adults were more commonly affected (57.2%) thanchildren and young adults (42.8%). Sixty percent of the affected
were females, as has also been observed in similar studies.12–14 The
disease was seen most commonly in immunized patients in the
months of October, December, January, and March, while in
unimmunized patients the peak months were September, Novem-
ber, and April.15,16 Studies carried out at different places in our
country have reported that diphtheria occurs more frequently
during the months from September to November.
Apart from prior antibiotic use, difﬁculties in proper sample
collection such as the patient’s inability to open their mouth wide
enough for a proper throat swab collection due to lymphadenop-
athy and edema/bull neck, resulted in low smear positivity (3.1%)
and isolation of organisms (18.8%). A study done by Ray et al.15
reported a similar low microbiological conﬁrmation rate for
clinical diphtheria. Culture was positive in 550 patients (18.9%).
The most common organism isolated was C. diphtheriae (72%),
followed by Corynebacterium other than diphtheriae, i.e., C.
ulcerans (15%), C. arcanobacterium (8%), and C. jeikeium (5%). In
the present study an important ﬁnding was isolation of
Corynebacterium other than diphtheriae from patients who
suffered from milder disease and recovered without complica-
tions. Majority of these patients (77.6%) were completely
immunized.
It was observed that 2844 patients who presented early in the
course of their illness and who received timely therapeutic
intervention, including prompt antitoxin administration, had a
better prognosis and recovered completely from the illness.17
Eighty-one patients who presented late with features of
severe toxemia died. Maximum number of deaths (n = 77)
occurred in the non-immunized group (95%), as shown in
Table 1. Five percent of deaths (4/81) occurred in immunized
patients aged <2 years. Several studies done across the globe
have reported diphtheria-related deaths in immunized chil-
dren.10 Aaby et al. reported increased mortality in immunized
infants in an observational study.11 This could be attributed to
infection occurring while the patient awaited a booster dose, or
to a lack of an antibody titer high enough to protect against
infection. Moreover, immunization by itself is reported to confer
only 95% protection, not 100%.7
The most common cause of death was myocarditis (66.6%).18
ECG abnormalities in those who developed myocarditis showed
conduction blocks and arrhythmias. In a brief communication by
Verghese et al., myocarditis was reported to be the only
independent predictor of death in diphtheria, with an adjusted
odds ratio of 25 and 95% conﬁdence interval (CI) of 3.4–210.3.8
In conclusion, in this study done from January 2008 to
December 2012, diphtheria, a communicable disease, was found
to affect all ages from 0 to 60 years, with a slight female gender
predisposition. Cases occurred in all geographical areas in and
around Hyderabad, AP, India where the study took place. The most
common clinical type was nasopharyngeal diphtheria. Myocarditis
was observed to be the most common complication. Patients who
were completely immunized against diphtheria suffered from
milder disease, and most of them recovered uneventfully. The
clinical illness in those patients whose throat swab culture yielded
Corynebacterium diphtheriae was severe when compared to disease
due to Corynebacterium other than diphtheriae. Deaths occurred
most commonly in the younger age group and in the non-
immunized. Recovery was faster and the course of illness
uncomplicated in the older age group and in completely
immunized individuals.
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